|
American Bio Medica Corporation - Comparative Business Analysis Snapshot
Business Description
American Bio Medica Corporation. The Group's principal activities are to develop, manufacture and sell immunoassay diagnostic test kits, primarily for the immediate, point of collection testing for drugs of abuse in urine and oral fluids (saliva). It also provides contract strip manufacturing services for other POCT diagnostic companies. Its drugs of abuse screening products offers employers, law enforcement, government, health care, laboratory and education professionals, self-contained, cost effective, user friendly screening devices capable of accurately identifying illicit drug use within minutes. The Group's products include Rapid ONE(R), Rapid TEC(R), Rapid TOX(R), Rapid TOX Cup(R), OralStat EX, Rapid STATT82, Rapid Reader(R), Rapid AlcoTECT82 and Rapid CheckT82. Its products are used in the Clinical,Physician, Hospital, emergency rooms, physicianoffices and rehabilitation facilities associated with hospitals. The Group markets its products in the North America, Europe, Asia/Pacific Rim.
Competitor Analysis
This analysis compares American Bio Medica Corporation with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
